Skip to main content
Sipai Health Technology Co., Ltd. logo

Sipai Health Technology Co., Ltd. — Investor Relations & Filings

Ticker · 314 ISIN · KYG8192S1021 LEI · 254900L2R8E2GUU04931 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 296 across all filing types
Latest filing 2026-05-27 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 314

About Sipai Health Technology Co., Ltd.

http://www.medbankshealthtech.com

Sipai Health Technology Co., Ltd. (Medbanks) is a leading medical technology and health management company in China, driving the digital transformation of healthcare. The company connects patients, providers, pharmaceutical companies, and commercial insurers through its data-enabled platform, delivering accessible medical services. Sipai operates three core business lines. The Specialty Pharmacy Business runs the largest privately owned specialty pharmacy network in China, offering drug supply, pharmacy care, and full-cycle disease management for specialty drugs. The Physician Research Assistance segment includes the largest oncology site management organization (SMO) for clinical trials and provides independent medical imaging assessment services for Phase I-IV clinical trials via Xiaoying Technology. The Health Insurance Services segment offers customized insurance brokerage, health management, and comprehensive benefits solutions to insurance companies, corporate clients, and millions of individuals.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return - Changes in issued shares and share buybacks
Transaction in Own Shares Classification · 90% confidence The document is a FF305 Next Day Disclosure Return under the Rules Governing the Listing of Securities on the Hong Kong Stock Exchange. It details changes in issued shares and treasury shares, including share repurchases on the market and issuance/transfer of treasury shares under a share scheme. This is a direct report of transactions in the company’s own shares (share buybacks and share issuances). Hence it falls under Transaction in Own Shares (POS).
2026-05-27 English
Form of proxy for the Annual General Meeting to be held on Thursday, June 18, 2026
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a form of proxy for the Annual General Meeting, clearly soliciting shareholder votes and providing proxy appointment instructions. This falls under materials sent to shareholders to request votes for meetings, matching the Proxy Solicitation & Information Statement definition.
2026-05-27 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a Notice of Annual General Meeting of Sipai Health Technology Co., Ltd. It contains the formal meeting invitation, agenda items/resolutions for shareholder approval, proxy instructions and related meeting details. It is not the report itself nor a results announcement, but rather the solicitation of shareholder votes for the AGM. Under the definitions, this falls under “Proxy Solicitation & Information Statement” (PSI).
2026-05-27 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a shareholder circular containing proposals for general mandates to issue and repurchase shares, re-election of directors, re-appointment of auditor, and the notice of the Annual General Meeting, together with forms of proxy. It is designed to solicit votes and provide information to shareholders ahead of the AGM. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-27 English
Next Day Disclosure Return - Changes in issued shares and share buybacks
Transaction in Own Shares Classification · 90% confidence The document is a Hong Kong Stock Exchange Form FF305 “Next Day Disclosure Return” detailing changes in issued shares and treasury shares, including share repurchases and exercise of share options (new issue of shares). It is a mandatory regulatory disclosure of the company’s own share transactions (buybacks, treasury sales, issuance). This aligns with the “Transaction in Own Shares” category (POS) rather than an annual report, earnings release, or miscellaneous regulatory notice.
2026-05-26 English
Next Day Disclosure Return - Changes in issued shares and share buybacks
Share Issue/Capital Change Classification · 97% confidence The document is a Next Day Disclosure Return (Form FF305) under the Hong Kong Listing Rules detailing changes in issued shares and treasury shares, including repurchases and issuances under share schemes. It is an announcement of share capital movements rather than a full financial report, earnings release, or management discussion. This falls under the “Share Issue/Capital Change” category, covering new share issues, treasury share transactions, and capital structure changes.
2026-05-22 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.